Download Free Sample Report@ https://www.meticulousresearch.com/download-sample-report/cp_id=5744?utm_source=pdf&utm_medium=social&utm_campaign=product&utm_content=03-07-2024
In the dynamic realm of genomic technologies, Europe’s Next-Generation Sequencing (NGS) market is set for remarkable growth, with projections indicating a rise to $6.40 billion by 2030, driven by a robust CAGR of 14.8%. This analysis, presented by Meticulous Research®, highlights the key drivers, challenges, and opportunities that are shaping the market’s future trajectory.
Key Drivers
Several catalysts are fueling the growth of Europe’s NGS market. The increasing prevalence of cancer and the expanding applications of NGS in cancer treatment and research are significant contributors. Additionally, declining costs of genome sequencing, technological advancements improving sequencing processes, and rising pharmaceutical R&D expenditures are propelling market expansion. However, the market faces challenges such as the high costs associated with NGS systems and consumables, along with competition from alternative technologies.
Emerging Opportunities
Despite these challenges, the market presents numerous opportunities. The growing adoption of bioinformatics and genomic data management solutions, coupled with government support for large-scale genomic sequencing projects, offers promising avenues for growth. Nevertheless, obstacles like a shortage of skilled professionals and regulatory concerns in diagnostic testing remain.
Key Market Players
Prominent players in Europe’s NGS market include Thermo Fisher Scientific Inc., Illumina, Inc., Qiagen N.V., and F. Hoffmann-La Roche Ltd., among others. These companies are at the forefront of innovation, driving the evolution of genomic technologies.
Market Segmentation and Outlook
The European NGS market spans various segments, including offering, sequencing type, technology, application, end user, and geography. Among these, consumables are critical, with the targeted genome sequencing segment taking the lead. Sequencing by synthesis technology holds the largest market share due to its accuracy and high throughput.
Geographic Insights
Germany stands out as the leading region in Europe’s NGS market, holding the largest share. This dominance is attributed to a growing number of sequencing projects, increasing applications in research, and heightened awareness of NGS-based tests.
As Europe’s NGS market continues to grow, stakeholders are poised to capitalize on the opportunities through innovation and strategic collaborations, unlocking the full potential of this burgeoning industry.Top of Form
Buy Now@ https://www.meticulousresearch.com/Checkout/37345289?utm_source=pdf&utm_medium=social&utm_campaign=product&utm_content=03-07-2024
About Meticulous Research®:
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research